Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries

Lancet
Paula BraitsteinART Cohort Collaboration (ART-CC) groups

Abstract

Highly active antiretroviral therapy (HAART) is being scaled up in developing countries. We compared baseline characteristics and outcomes during the first year of HAART between HIV-1-infected patients in low-income and high-income settings. 18 HAART programmes in Africa, Asia, and South America (low-income settings) and 12 HIV cohort studies from Europe and North America (high-income settings) provided data for 4810 and 22,217, respectively, treatment-naïve adult patients starting HAART. All patients from high-income settings and 2725 (57%) patients from low-income settings were actively followed-up and included in survival analyses. Compared with high-income countries, patients starting HAART in low-income settings had lower CD4 cell counts (median 108 cells per muL vs 234 cells per muL), were more likely to be female (51%vs 25%), and more likely to start treatment with a non-nucleoside reverse transcriptase inhibitor (NNRTI) (70%vs 23%). At 6 months, the median number of CD4 cells gained (106 cells per muL vs 103 cells per muL) and the percentage of patients reaching HIV-1 RNA levels lower than 500 copies/mL (76%vs 77%) were similar. Mortality was higher in low-income settings (124 deaths during 2236 person-years of follow-u...Continue Reading

References

Dec 9, 1997·Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association·J D LundgrenC Pedersen
Jul 9, 1998·American Journal of Respiratory and Critical Care Medicine·M NaritaA E Pitchenik
Feb 15, 2001·Journal of Acquired Immune Deficiency Syndromes : JAIDS·S L BeckerUNKNOWN Collaborations in HIV Outcomes Research--US (CHORUS) Program Team
Sep 26, 2001·Archives of Internal Medicine·P T NieuwkerkUNKNOWN ATHENA Project
Feb 21, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Charles B HolmesKenneth A Freedberg
Apr 13, 2004·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Xavier AnglaretGeneviève Chêne
Apr 29, 2004·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·L AaronO Lortholary
Dec 21, 2004·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Christian LaurentUNKNOWN ANRS 1215/1290 Study Group
Jan 27, 2005·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Jialun ZhouUNKNOWN TREAT Asia HIV Observational Database
Apr 5, 2005·American Journal of Respiratory and Critical Care Medicine·Catherine SeylerXavier Anglaret
Jun 9, 2005·International Journal of Epidemiology·Matthias EggerPaolo Miotti
Jun 29, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Louise C IversKaren Doucette
Sep 15, 2005·International Journal of Epidemiology·François DabisUNKNOWN Antiviral Therpapy in Lower Income Countries (ART-LINC) Study Group
Dec 2, 2005·The New England Journal of Medicine·Patrice SevereDaniel W Fitzgerald

❮ Previous
Next ❯

Citations

Sep 24, 2008·Archives of Internal Medicine·Eran BendavidDouglas K Owens
Aug 5, 2008·JAMA : the Journal of the American Medical Association·Elvin H GengJeffrey N Martin
Jul 17, 2008·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·R E BarthH A Tempelman
Oct 13, 2006·Current HIV/AIDS Reports·Kara Wools-Kaloustian, Sylvester Kimaiyo
Jun 6, 2007·Current HIV/AIDS Reports·Anna K PersonNathan M Thielman
Oct 24, 2009·Current HIV/AIDS Reports·Edward J MillsOghenowede Eyawo
May 30, 2013·Current HIV/AIDS Reports·Ana-Claire Meyer, Mark Jacobson
Nov 18, 2008·Transactions of the Royal Society of Tropical Medicine and Hygiene·Peter MacPhersonPaul Pronyk
Mar 21, 2009·Transactions of the Royal Society of Tropical Medicine and Hygiene·M MassaquoiAnthony D Harries
Feb 9, 2010·Transactions of the Royal Society of Tropical Medicine and Hygiene·Katie Tayler-SmithAnthony D Harries
Oct 4, 2011·Transactions of the Royal Society of Tropical Medicine and Hygiene·Johan van Griensven, Sopheak Thai
Mar 5, 2010·The New England Journal of Medicine·Neil FrenchCharles F Gilks
Jun 18, 2010·The New England Journal of Medicine·R L ShapiroM Essex
Jul 20, 2011·The New England Journal of Medicine·Myron S CohenUNKNOWN HPTN 052 Study Team
Dec 1, 2011·Sexual Health·Margaret T May, Suzanne M Ingle
Aug 17, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Stephen D LawnRobin Wood
Jan 24, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Thanyawee PuthanakitVirat Sirisanthana
Nov 9, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·UNKNOWN Antiretroviral Therapy in Low-Income Countries Collaboration of the International epidemiological Databases to Evaluate AIDSMauro Schechter
Nov 9, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Habib O RamadhaniJohn A Crump
Nov 9, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Timothy P FlaniganE Jane Carter
Jan 17, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Glenda E Gray
Feb 15, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ferdinand W N M WitPeter Reiss
Aug 12, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Fujie ZhangRay Y Chen
Oct 22, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Christopher J HoffmannChloe L Thio
Jan 1, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Leonardo PalombiUNKNOWN DREAM Program
Nov 26, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Martyn A French
Jan 7, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Elvin H Geng, Steven G Deeks
Feb 6, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Colleen F KelleySteven G Deeks
Feb 12, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Serena P KoenigDaniel W Fitzgerald
Feb 20, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Preeyaporn SrasuebkulMatthew G Law

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.